Literature DB >> 22537432

Epidemiology of viral hepatitis and hepatocellular carcinoma.

Hashem B El-Serag1.   

Abstract

Most cases of hepatocellular carcinoma (HCC) are associated with cirrhosis related to chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. Changes in the time trends of HCC and most variations in its age-, sex-, and race-specific rates among different regions are likely to be related to differences in hepatitis viruses that are most prevalent in a population, the timing of their spread, and the ages of the individuals the viruses infect. Environmental, host genetic, and viral factors can affect the risk of HCC in individuals with HBV or HCV infection. This review summarizes the risk factors for HCC among HBV- or HCV-infected individuals, based on findings from epidemiologic studies and meta-analyses, as well as determinants of patient outcome and the HCC disease burden, globally and in the United States.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22537432      PMCID: PMC3338949          DOI: 10.1053/j.gastro.2011.12.061

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  50 in total

1.  A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China.

Authors:  J M Yuan; R K Ross; F Z Stanczyk; S Govindarajan; Y T Gao; B E Henderson; M C Yu
Journal:  Int J Cancer       Date:  1995-11-15       Impact factor: 7.396

2.  Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.

Authors:  M J Tong; L P Lai; K Murakami-Mori
Journal:  West J Med       Date:  1997-08

3.  Association between chronic hepatitis C infection and hepatocellular carcinoma.

Authors:  G H Haydon; L M Jarvis; P Simmonds; P C Hayes
Journal:  Lancet       Date:  1995-04-08       Impact factor: 79.321

4.  Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males.

Authors:  Donna L White; Shariar Tavakoli-Tabasi; Jill Kuzniarek; Rhia Pascua; David J Ramsey; Hashem B El-Serag
Journal:  Hepatology       Date:  2011-12-14       Impact factor: 17.425

5.  A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma.

Authors:  F Donato; P Boffetta; M Puoti
Journal:  Int J Cancer       Date:  1998-01-30       Impact factor: 7.396

6.  Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.

Authors:  Sun Ha Jee; Heechoul Ohrr; Jae Woong Sull; Jonathan M Samet
Journal:  J Natl Cancer Inst       Date:  2004-12-15       Impact factor: 13.506

Review 7.  Molecular evolution of hepatitis viruses.

Authors:  M Mizokami; E Orito
Journal:  Intervirology       Date:  1999       Impact factor: 1.763

8.  Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma.

Authors:  Yen-Hsuan Ni; Mei-Hwei Chang; Kuan-Jan Wang; Hong-Yuan Hsu; Huey-Ling Chen; Jia-Horng Kao; Shiou-Hwei Yeh; Yung-Ming Jeng; Keh-Sung Tsai; Ding-Shinn Chen
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

9.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.

Authors:  G S Qian; R K Ross; M C Yu; J M Yuan; Y T Gao; B E Henderson; G N Wogan; J D Groopman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Jan-Feb       Impact factor: 4.254

10.  Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients.

Authors:  K Ikeda; S Saitoh; Y Suzuki; M Kobayashi; A Tsubota; I Koida; Y Arase; M Fukuda; K Chayama; N Murashima; H Kumada
Journal:  J Hepatol       Date:  1998-06       Impact factor: 25.083

View more
  1180 in total

1.  Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program.

Authors:  Henry J Pollack; Simona C Kwon; Su H Wang; Laura C Wyatt; Chau Trinh-Shevrin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11       Impact factor: 4.254

2.  Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.

Authors:  Yasushi Totoki; Kenji Tatsuno; Kyle R Covington; Hiroki Ueda; Chad J Creighton; Mamoru Kato; Shingo Tsuji; Lawrence A Donehower; Betty L Slagle; Hiromi Nakamura; Shogo Yamamoto; Eve Shinbrot; Natsuko Hama; Megan Lehmkuhl; Fumie Hosoda; Yasuhito Arai; Kim Walker; Mahmoud Dahdouli; Kengo Gotoh; Genta Nagae; Marie-Claude Gingras; Donna M Muzny; Hidenori Ojima; Kazuaki Shimada; Yutaka Midorikawa; John A Goss; Ronald Cotton; Akimasa Hayashi; Junji Shibahara; Shumpei Ishikawa; Jacfranz Guiteau; Mariko Tanaka; Tomoko Urushidate; Shoko Ohashi; Naoko Okada; Harsha Doddapaneni; Min Wang; Yiming Zhu; Huyen Dinh; Takuji Okusaka; Norihiro Kokudo; Tomoo Kosuge; Tadatoshi Takayama; Masashi Fukayama; Richard A Gibbs; David A Wheeler; Hiroyuki Aburatani; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2014-11-02       Impact factor: 38.330

3.  Accelerated carcinogenesis following liver resection in chronically inflamed livers: A window of opportunity for treatment.

Authors:  Amir Sonnenblick; Tamar Zahavi
Journal:  Biomed Rep       Date:  2017-03-30

4.  Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice.

Authors:  Zhuona Rong; Tingting Fan; Huiling Li; Juan Li; Kangwei Wang; Xinxin Wang; Jianyi Dong; Jun Chen; Fujin Wang; Jingyu Wang; Aiguo Wang
Journal:  Mol Cell Proteomics       Date:  2017-05-16       Impact factor: 5.911

5.  Stem cell gene SALL4 in aggressive hepatocellular carcinoma: a cancer stem cell-specific target?

Authors:  Elizabeth Yakaboski; Alexander Jares; Yupo Ma
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

6.  Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma.

Authors:  Benjamin Yip; James M Wantuck; Lily H Kim; Robert J Wong; Aijaz Ahmed; Gabriel Garcia; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

7.  HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy.

Authors:  T-W Wu; C-C Chu; H-W Chang Liao; S-K Lin; T-Y Ho; M Lin; H H Lin; L-Y Wang
Journal:  Genes Immun       Date:  2013-11-28       Impact factor: 2.676

8.  Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.

Authors:  Xueping Qiu; Bo Hu; Yifang Huang; Yunte Deng; Xuebin Wang; Fang Zheng
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

9.  Effect of branched-chain amino acid supplementation on insulin resistance and quality of life in chronic hepatitis C patients.

Authors:  Alicia Ocaña-Mondragón; José Antonio Mata-Marín; Mario Uriarte-López; Carolina Bekker-Méndez; Enrique Alcalá-Martínez; Rosa María Ribas-Aparicio; Luis Antonio Uribe-Noguéz; Dulce María Rodríguez-Galindo; María de La Luz Martínez-Rodríguez
Journal:  Biomed Rep       Date:  2017-11-03

10.  Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.

Authors:  Charlotte E Edling; Federico Selvaggi; Ragheda Ghonaim; Tania Maffucci; Marco Falasca
Journal:  Cancer Biol Ther       Date:  2014-02-12       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.